STATE OF WISCONSIN
Controlled Substances Board
IN THE MATTER OF RULE-MAKING PROCEEDINGS BEFORE THE
CONTROLLED SUBSTANCES BOARD
AFFIRMATIVE ACTION ORDER OF THE
CONTROLLED SUBSTANCES BOARD
FINDINGS
1. On August 26, 2016, the Department of Justice, Drug Enforcement Administration published its final rule in the Federal Register placing thiafentanil into schedule II of the federal Controlled Substances Act. The scheduling action is effective August 26, 2016.
2. The Controlled Substances Board did not receive an objection to similarly treating thiafentanil as a schedule II under ch. 961, Stats. within 30 days of the date of publication in the federal register of the final order designating thiafentanil as a controlled substance. 3. The Controlled Substances Board will promulgate a final rule, without making the determinations or findings required by ss. 961.11(1), (1m), (1r) and (2) or s. 961.19 and omitting the notice of proposed rule making, designating thiafentanil as a schedule II controlled substance. ORDER
Pursuant to s. 961.11(4), Stats., the Controlled Substances Board by affirmative action similarly treats thiafentanil under chapter 961, Stats. by creating the following: CSB 2.44 Addition of thiafentanil to schedule II. Section 961.16(3)(zx), Stats., is created to read: 961.16(3)(zx) Thiafentanil.
This order shall take effect on October 3, 2016 to allow for publication in the Administrative Register. The order expires upon promulgation of a final rule.
Dated September 27, 2016 
Doug Englebert, Chair
Controlled Substances Board
